Cancer Insights

Clear filters
Non-small cell lung cancer. Credit: Yale Rosen

Practice-Changing Developments in Treatment of Metastatic NSCLC

In-Depth Insights |  Written by Emma Shtivelman, PhD

Immune checkpoint inhibitor drugs that target the proteins PD-1 and PD-L1 are by now well established in the treatment of non-small cell ...

Learn More